Yun Yen

22.7k total citations · 4 hit papers
369 papers, 15.2k citations indexed

About

Yun Yen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yun Yen has authored 369 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Molecular Biology, 149 papers in Oncology and 79 papers in Cancer Research. Recurrent topics in Yun Yen's work include RNA modifications and cancer (55 papers), Metal-Catalyzed Oxygenation Mechanisms (36 papers) and Cancer-related Molecular Pathways (28 papers). Yun Yen is often cited by papers focused on RNA modifications and cancer (55 papers), Metal-Catalyzed Oxygenation Mechanisms (36 papers) and Cancer-related Molecular Pathways (28 papers). Yun Yen collaborates with scholars based in United States, Taiwan and China. Yun Yen's co-authors include Mark E. Davis, Bingsen Zhou, Jonathan E. Zuckerman, Jeremy D. Heidel, Anthony W. Tolcher, Antoni Ribas, Xiyong Liu, Chung Hang Jonathan Choi, David B. Seligson and Christopher A. Alabi and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Yun Yen

365 papers receiving 14.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

2010 1.9k citations Mark E. Davis, Yun Yen et al. profile →
Enabling Technologies for Personalized and Precision Medicine

2020 264 citations Yun Yen et al. profile →
Arginine Signaling and Cancer Metabolism

2021 173 citations David K. Ann, Yun Yen et al. profile →
Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials

2024 89 citations Yun Yen et al. profile →

Peers

Countries citing papers authored by Yun Yen

Since Specialization

Citations

This map shows the geographic impact of Yun Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Yen more than expected).

Fields of papers citing papers by Yun Yen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Yen. The network helps show where Yun Yen may publish in the future.

Co-authorship network of co-authors of Yun Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Yen. A scholar is included among the top collaborators of Yun Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Yen. Yun Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor 2024 ·Neoplasia ·(unknown), Kuo-Sheng Wu, Wei-Chung Allen Lee, (unknown), (unknown), (unknown), Yu‐Ling Lin, Chia‐Ling Hsieh, Shian‐Ying Sung, Yun Yen, Tai‐Tong Wong, Che‐Chang Chang	1
2	Machine Learning–Based Radiomics for Molecular Subtyping of Gliomas 2018 ·Clinical Cancer Research ·Chia‐Feng Lu, Fei‐Ting Hsu, Kevin Li‐Chun Hsieh, Yu‐Chieh Jill Kao, Sho‐Jen Cheng, Justin Bo‐Kai Hsu, Ping‐Huei Tsai, Ray‐Jade Chen, Chao Huang, Yun Yen, Cheng‐Yu Chen	210
3	Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer 2017 ·Clinical Cancer Research ·Chun‐Han Chen, Chun A. Changou, Tsung‐Han Hsieh, Yu‐Ching Lee, Cheng-Ying Chu, Kai‐Cheng Hsu, Hao‐Ching Wang, Yu‐Chen Lin, (unknown), Yun-Ru Liu, Jing‐Ping Liou, Yun Yen	43
4	A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential 2014 ·Clinical Cancer Research ·Yunping Qiu, Guoxiang Cai, Bingsen Zhou, Dan Li, Aihua Zhao, Guoxiang Xie, Houkai Li, Sanjun Cai, Dong Xie, Changzhi Huang, Weiting Ge, Zhanxiang Zhou, Lisa X. Xu, Weiping Jia, Shu Zheng, Yun Yen, Wei Jia	142
5	p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses 2014 ·Clinical Cancer Research ·Nicola Hardwick, Mary Carroll, Teodora Kaltcheva, (unknown), Dean Lim, Lucille Leong, Peiguo Chu, Joseph Kim, Joseph Chao, Marwan Fakih, Yun Yen, (unknown), Joshua D.I. Ellenhorn, Don J. Diamond, Vincent Chung	35
6	Frequent Overexpression of HMGA2 in Human Atypical Teratoid/Rhabdoid Tumor and Its Correlation with let-7a3/let-7b miRNA 2014 ·Clinical Cancer Research ·Keqiang Zhang, Hanlin Gao, Xiwei Wu, Jinhui Wang, Wendi Zhou, Guihua Sun, Jinghan Wang, Yafan Wang, Bing Mu, Charles C. Kim, Peiguo Chu, Donald Ming-Tak Ho, David K. Ann, Tai‐Tong Wong, Yun Yen	32
7	A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance 2013 ·Cancer Research ·Bingsen Zhou, Leila Su, Shuya Hu, Weidong Hu, M.L. Richard Yip, Jun Wu, Shikha Gaur, D. Lynne Smith, Yate‐Ching Yuan, Timothy W. Synold, David Horne, Yun Yen	65
8	Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade Liposarcoma 2013 ·Cancer Research ·Keqiang Zhang, Kevin Chu, Xiwei Wu, Hanlin Gao, Jinhui Wang, Yate‐Ching Yuan, Sofia Loera, (unknown), Yafan Wang, Warren Chow, Frank Un, Peiguo Chu, Yun Yen	84
9	Berbamine Inhibits the Growth of Liver Cancer Cells and Cancer-Initiating Cells by Targeting Ca2+/Calmodulin-Dependent Protein Kinase II 2013 ·Molecular Cancer Therapeutics ·Zhipeng Meng, Tao Li, Xiaoxiao Ma, Xiaoqiong Wang, Carl Van Ness, Yichao Gan, Hong Zhou, (unknown), Guiyu Lou, Yafan Wang, Jun Wu, Yun Yen, Rongzhen Xu, Wendong Huang	72
10	Bcl2 Induces DNA Replication Stress by Inhibiting Ribonucleotide Reductase 2013 ·Cancer Research ·Maohua Xie, Yun Yen, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri, Walter J. Curran, Paul W. Doetsch, Xingming Deng	39
11	Secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers 2012 ·Clinical Cancer Research ·Hanguang Hu, Hang Zhang, Weiting Ge, Xiyong Liu, Sofia Loera, Peiguo Chu, Huarong Chen, Jiaping Peng, Lun Zhou, (unknown), Ying Yuan, (unknown), Lily Lai, Yun Yen, Shu Zheng	38
12	Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer 2011 ·Cancer Research ·Xiyong Liu, Lily Lai, Xiaochen Wang, Lijun Xue, (unknown), Jun Wu, Shuya Hu, Keqiang Zhang, Mei-Ling Kuo, Lun Zhou, Hang Zhang, Yafan Wang, Yan Wang, Bingsen Zhou, Rebecca A. Nelson, Shu Zheng, Suzhan Zhang, Peiguo Chu, Yun Yen	52
13	Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers 2011 ·Clinical Cancer Research ·Xiaochen Wang, Xiyong Liu, (unknown), Lirong Chen, Lily Lai, H. Helen Lin, Shuya Hu, Lifang Yao, Jiaping Peng, Sofia Loera, Lijun Xue, Bingsen Zhou, Lun Zhou, Shu Zheng, Peiguo Chu, Suzhan Zhang, David K. Ann, Yun Yen	151
14	p53R2 Inhibits the Proliferation of Human Cancer Cells in Association with Cell-Cycle Arrest 2011 ·Molecular Cancer Therapeutics ·Keqiang Zhang, Jun Wu, Xiwei Wu, Xiaochen Wang, Yan Wang, Ning Zhou, Mei-Ling Kuo, Xiyong Liu, Bingsen Zhou, Lufen Chang, David K. Ann, Yun Yen	43
15	Combining Histone Deacetylase Inhibitor Vorinostat with Aurora Kinase Inhibitors Enhances Lymphoma Cell Killing with Repression of c-Myc, hTERT, and microRNA Levels 2011 ·Cancer Research ·Leo Kretzner, Anna Scuto, (unknown), Claudia Kowolik, Jun Wu, Patrick Ventura, Richard Jove, Stephen J. Forman, Yun Yen, Mark Kirschbaum	89
16	Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication 2010 ·Cancer Research ·Brent J. Passer, Tooba A. Cheema, Bingsen Zhou, Hiroaki Wakimoto, Cécile Zaupa, (unknown), (unknown), Shulin Wu, Chin‐Lee Wu, James W. Noah, Qianjun Li, John K. Buolamwini, Yun Yen, Samuel D. Rabkin, Robert L. Martuza	26
17	Antitumor Activity of Targeting Src Kinases in Endothelial and Myeloid Cell Compartments of the Tumor Microenvironment 2010 ·Clinical Cancer Research ·Wei Liang, Maciej Kujawski, Jun Wu, Jianming Lu, Andreas Herrmann, Sofia Loera, Yun Yen, Frank Lee, Hua Yu, Wei Wen, Richard Jove	51
18	Suppression of Nonhomologous End Joining Repair by Overexpression of HMGA2 2009 ·Cancer Research ·(unknown), (unknown), Shih-Ya Wang, H. Helen Lin, Clay C. C. Wang, Yun Yen, Benjamin P.C. Chen, David J. Chen, David K. Ann	68
19	Potent siRNA Inhibitors of Ribonucleotide Reductase Subunit RRM2 Reduce Cell Proliferation In vitro and In vivo 2007 ·Clinical Cancer Research ·Jeremy D. Heidel, (unknown), Yun Yen, Bingsen Zhou, Bret S.E. Heale, John J. Rossi, Derek W. Bartlett, Mark E. Davis	130
20	Spontaneous Development of Liver Tumors in the Absence of the Bile Acid Receptor Farnesoid X Receptor 2007 ·Cancer Research ·Fan Yang, Xiongfei Huang, Tangsheng Yi, Yun Yen, David D. Moore, Wendong Huang	393

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact